Literature DB >> 29665359

Lipidomic insight into cardiovascular diseases.

Shohei Kohno1, Audrey L Keenan1, James M Ntambi2, Makoto Miyazaki3.   

Abstract

Cardiovascular disease is a primary cause of mortality worldwide. Therefore, it is of major interest to identify sensitive molecular markers that predict cardiovascular events and point to therapeutic strategies that will increase lifespans. Dysregulated lipid metabolism is recognized as an established risk factor in cardiovascular diseases. However, it is still largely unknown which specific lipid molecular species reflect cardiovascular risk. In addition, understanding the whole lipidome signature in vascular pathophysiology is challenging. Recent advancements of mass-spectrometry allow researchers to detect each individual lipid species from unbiased small samples. In this review, we update the current research on lipidomic approaches in cardiovascular diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Lipid metabolism; Lipidomics; Metabolomics

Mesh:

Substances:

Year:  2018        PMID: 29665359      PMCID: PMC6309221          DOI: 10.1016/j.bbrc.2018.04.106

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Comparative lipidomics profiling of human atherosclerotic plaques.

Authors:  Christin Stegemann; Ignat Drozdov; Joseph Shalhoub; Julia Humphries; Christophe Ladroue; Athanasios Didangelos; Mark Baumert; Mark Allen; Alun H Davies; Claudia Monaco; Alberto Smith; Qingbo Xu; Manuel Mayr
Journal:  Circ Cardiovasc Genet       Date:  2011-04-21

2.  Coronary heart disease in the Framingham study.

Authors:  T R DAWBER; F E MOORE; G V MANN
Journal:  Am J Public Health Nations Health       Date:  1957-04

Review 3.  Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics.

Authors:  Xianlin Han; Richard W Gross
Journal:  J Lipid Res       Date:  2003-04-01       Impact factor: 5.922

4.  Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.

Authors:  Zahir H Alshehry; Piyushkumar A Mundra; Christopher K Barlow; Natalie A Mellett; Gerard Wong; Malcolm J McConville; John Simes; Andrew M Tonkin; David R Sullivan; Elizabeth H Barnes; Paul J Nestel; Bronwyn A Kingwell; Michel Marre; Bruce Neal; Neil R Poulter; Anthony Rodgers; Bryan Williams; Sophia Zoungas; Graham S Hillis; John Chalmers; Mark Woodward; Peter J Meikle
Journal:  Circulation       Date:  2016-10-18       Impact factor: 29.690

5.  Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.

Authors:  Bill Davis; Grielof Koster; Lisa J Douet; Michaela Scigelova; Gary Woffendin; Joanna M Ward; Alberto Smith; Julia Humphries; Kevin G Burnand; Colin H Macphee; Anthony D Postle
Journal:  J Biol Chem       Date:  2007-12-29       Impact factor: 5.157

6.  Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype.

Authors:  Eugene A Podrez; Tatiana V Byzova; Maria Febbraio; Robert G Salomon; Yi Ma; Manojkumar Valiyaveettil; Eugenia Poliakov; Mingjiang Sun; Paula J Finton; Brian R Curtis; Juhua Chen; Renliang Zhang; Roy L Silverstein; Stanley L Hazen
Journal:  Nat Med       Date:  2007-08-26       Impact factor: 53.440

7.  Replication of LC-MS untargeted lipidomics results in patients with calcific coronary disease: An interlaboratory reproducibility study.

Authors:  Demir Djekic; Rui Pinto; Panagiotis A Vorkas; Michael Y Henein
Journal:  Int J Cardiol       Date:  2016-08-02       Impact factor: 4.164

8.  Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease.

Authors:  Helmut Hinterwirth; Christin Stegemann; Manuel Mayr
Journal:  Circ Cardiovasc Genet       Date:  2014-12

9.  Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease.

Authors:  Andrea Ganna; Samira Salihovic; Johan Sundström; Corey D Broeckling; Asa K Hedman; Patrik K E Magnusson; Nancy L Pedersen; Anders Larsson; Agneta Siegbahn; Mihkel Zilmer; Jessica Prenni; Johan Arnlöv; Lars Lind; Tove Fall; Erik Ingelsson
Journal:  PLoS Genet       Date:  2014-12-11       Impact factor: 5.917

10.  Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases.

Authors:  Jianhong Lu; Buxing Chen; Tingting Chen; Shuyuan Guo; Xinli Xue; Qun Chen; Mingming Zhao; Lin Xia; Zhengjiang Zhu; Lemin Zheng; Huiyong Yin
Journal:  Redox Biol       Date:  2017-04-26       Impact factor: 11.799

View more
  16 in total

1.  Circulating and tissue biomarkers as predictors of bromine gas inhalation.

Authors:  Juan Xavier Masjoan Juncos; Shazia Shakil; Aamir Ahmad; Duha Aishah; Charity J Morgan; Louis J Dell'Italia; David A Ford; Aftab Ahmad; Shama Ahmad
Journal:  Ann N Y Acad Sci       Date:  2020-07-09       Impact factor: 5.691

2.  Changes in lipidomic profile by anti-retroviral treatment regimen: An ACTG 5257 ancillary study.

Authors:  Ninad S Chaudhary; Tobias Kind; Amanda L Willig; Michael S Saag; Sadeep Shrestha; Nicholas Funderburg; Howard W Wiener; E Turner Overton; Marguerite R Irvin
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

3.  Editorial for BBRC lipidomics special issue.

Authors:  Sarah Spiegel; James Ntambi
Journal:  Biochem Biophys Res Commun       Date:  2018-10-07       Impact factor: 3.575

Review 4.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

5.  Investigation of stationary phases performance for eicosanoids profiling in RP-HPLC.

Authors:  Kodjo Nouwade; Sana Tfaili; Pierre Chaminade
Journal:  Anal Bioanal Chem       Date:  2021-09-02       Impact factor: 4.142

6.  Alterations in the gut microbiome and metabolism with coronary artery disease severity.

Authors:  Honghong Liu; Xi Chen; Xiaomin Hu; Haitao Niu; Ran Tian; Hui Wang; Haiyu Pang; Lingjuan Jiang; Bintao Qiu; Xiuting Chen; Yang Zhang; Yiyangzi Ma; Si Tang; Hanyu Li; Siqin Feng; Shuyang Zhang; Chenhong Zhang
Journal:  Microbiome       Date:  2019-04-26       Impact factor: 14.650

7.  From Prevention to Disease Perturbations: A Multi-Omic Assessment of Exercise and Myocardial Infarctions.

Authors:  Melanie T Odenkirk; Kelly G Stratton; Lisa M Bramer; Bobbie-Jo M Webb-Robertson; Kent J Bloodsworth; Matthew E Monroe; Kristin E Burnum-Johnson; Erin S Baker
Journal:  Biomolecules       Date:  2020-12-30

8.  Imaging of lysophosphatidylcholine in an induced pluripotent stem cell-derived endothelial cell network.

Authors:  Yasuo Shimizu; Yusuke Nakamura; Yasuhiro Horibata; Mio Fujimaki; Keitaro Hayashi; Nobuhiko Uchida; Hiroko Morita; Ryo Arai; Kazuyuki Chibana; Akihiro Takemasa; Hiroyuki Sugimoto
Journal:  Regen Ther       Date:  2020-05-18       Impact factor: 3.419

9.  Pulsatilla Decoction Can Treat the Dampness-Heat Diarrhea Rat Model by Regulating Glycerinphospholipid Metabolism Based Lipidomics Approach.

Authors:  Yong-Li Hua; Qi Ma; Xiao-Song Zhang; Ya-Qian Jia; Xiao-Ting Peng; Wan-Ling Yao; Peng Ji; Jun-Jie Hu; Yan-Ming Wei
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

10.  Atheroma-Specific Lipids in ldlr-/- and apoe-/- Mice Using 2D and 3D Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.

Authors:  Jianhua Cao; Pieter Goossens; Marta Martin-Lorenzo; Frédéric Dewez; Britt S R Claes; Erik A L Biessen; Ron M A Heeren; Benjamin Balluff
Journal:  J Am Soc Mass Spectrom       Date:  2020-08-12       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.